Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun 28:36:11616.
doi: 10.3389/ti.2023.11616. eCollection 2023.

Prime Time for HLA Desensitization: Imlifidase in the Spotlight

Oriol Bestard  1 , Francesc Moreso  1 , Anthony Dorling  2
Affiliations
Comment

Prime Time for HLA Desensitization: Imlifidase in the Spotlight

Oriol Bestard et al. Transpl Int. .
No abstract available

Keywords: HLA allosensitization; desensitization; rejection; survival benefit; transplant access.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Mamode N, Bestard O, Claas F, Furian L, Griffin S, Legendre C, et al. European Guideline for the Management of Kidney Transplant Patients with HLA Antibodies: By the European Society for Organ Transplantation Working Group. Transpl Int (2022) 35:10511. 10.3389/ti.2022.10511 - DOI - PMC - PubMed
    1. Manook M, Koeser L, Ahmed Z, Robb M, Johnson R, Shaw O, et al. Post-Listing Survival for Highly Sensitised Patients on the UK Kidney Transplant Waiting List: a Matched Cohort Analysis. Lancet (2017) 389(10070):727–34. 10.1016/S0140-6736(16)31595-1 - DOI - PubMed
    1. Bestard O, Couzi L, Crespo M, Kessaris N, Thaunat O. Stratifying the Humoral Risk of Candidates to a Solid Organ Transplantation: a Proposal of the ENGAGE Working Group. Transpl Int (2021) 34:1005–18. 10.1111/tri.13874 - DOI - PubMed
    1. Huang E, Maldonado AQ, Kjellman C, Jordan SC. Imlifidase for the Treatment of Anti-HLA Antibody-Mediated Processes in Kidney Transplantation. Am J Transpl (2021) 22:691–7. 10.1111/ajt.16828 - DOI - PMC - PubMed
    1. Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med (2017) 377(5):442–53. 10.1056/nejmoa1612567 - DOI - PubMed